Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

July 2017 - FRMC

Department

Conference Insider
07/31/2017
Medicare Advantage prescription drug plan members experience more medication-related problems, such as problems with adherence, when compared to other prescription drug plan members, according to a poster presented at ASHP’s 2017 Summer...
Medicare Advantage prescription drug plan members experience more medication-related problems, such as problems with adherence, when compared to other prescription drug plan members, according to a poster presented at ASHP’s 2017 Summer...
Medicare Advantage prescription...
07/31/2017
First Report Managed Care
Conference Insider
07/31/2017
A study presented at the American Diabetes Association’s 77th Scientific Sessions found that the impact diabetes drug copays have on patients vary widely between generic and branded products.
A study presented at the American Diabetes Association’s 77th Scientific Sessions found that the impact diabetes drug copays have on patients vary widely between generic and branded products.
A study presented at the...
07/31/2017
First Report Managed Care
Conference Insider
07/31/2017
After implementation of the Affordable Care Act, health related quality of life was higher among adult patients with type 2 diabetes, according to a presentation at the American Diabetes Association’s 77th Scientific Sessions.
After implementation of the Affordable Care Act, health related quality of life was higher among adult patients with type 2 diabetes, according to a presentation at the American Diabetes Association’s 77th Scientific Sessions.
After implementation of the...
07/31/2017
First Report Managed Care
Conference Insider
07/31/2017
According to recent research presented at the American Diabetes Association’s 77th Scientific Sessions, adopting a professional continuous glucose monitoring could significantly improve diabetes management and cut per-patients costs for...
According to recent research presented at the American Diabetes Association’s 77th Scientific Sessions, adopting a professional continuous glucose monitoring could significantly improve diabetes management and cut per-patients costs for...
According to recent research...
07/31/2017
First Report Managed Care
Conference Insider
07/31/2017
Recent research presented at the American Diabetes Association’s 77th Scientific Sessions showed that patients with type 2 diabetes who self-monitored blood glucose levels failed to improve glycemic control.
Recent research presented at the American Diabetes Association’s 77th Scientific Sessions showed that patients with type 2 diabetes who self-monitored blood glucose levels failed to improve glycemic control.
Recent research presented at the...
07/31/2017
First Report Managed Care
Conference Insider
07/31/2017
A presentation at the American Diabetes Association’s 77th Scientific Sessions showed that oral insulin achieved similar HbA1c and fasting plasma glucose levels in patients with type 2 diabetes compared with subcutaneous insulin injections.
A presentation at the American Diabetes Association’s 77th Scientific Sessions showed that oral insulin achieved similar HbA1c and fasting plasma glucose levels in patients with type 2 diabetes compared with subcutaneous insulin injections.
A presentation at the American...
07/31/2017
First Report Managed Care
Conference Insider
07/31/2017
New clinical trial data presented at the American Diabetes Association’s 77th Scientific Sessions showed that a once-daily shot of Xultophy100/3.6 (insulin degludec and liraglutide injection; Novo Nordisk) was more effective and less costly...
New clinical trial data presented at the American Diabetes Association’s 77th Scientific Sessions showed that a once-daily shot of Xultophy100/3.6 (insulin degludec and liraglutide injection; Novo Nordisk) was more effective and less costly...
New clinical trial data...
07/31/2017
First Report Managed Care
Conference Insider
07/31/2017
Two studies presented at the 2017 EULAR Congress confirmed that biologic disease- modifying anti-rheumatic drugs (DMARDs), including anti-TNF treatments, do not increase the risk of cancer in patients with RA.
Two studies presented at the 2017 EULAR Congress confirmed that biologic disease- modifying anti-rheumatic drugs (DMARDs), including anti-TNF treatments, do not increase the risk of cancer in patients with RA.
Two studies presented at the...
07/31/2017
First Report Managed Care
Conference Insider
07/31/2017
A number of studies presented at the 2017 EULAR Congress highlighted recent advancements in existing drug classes and new drug classes for the treatment of osteoporosis in postmenopausal women.  
A number of studies presented at the 2017 EULAR Congress highlighted recent advancements in existing drug classes and new drug classes for the treatment of osteoporosis in postmenopausal women.  
A number of studies presented at...
07/31/2017
First Report Managed Care
Department
07/31/2017
A poster presented at the ASHP’s 2017 Summer Meetings and Exhibition outlined the strategies crucial to a successful pharmacist-physician integrated comprehensive medication management (CMM) program.
A poster presented at the ASHP’s 2017 Summer Meetings and Exhibition outlined the strategies crucial to a successful pharmacist-physician integrated comprehensive medication management (CMM) program.
A poster presented at the ASHP’s...
07/31/2017
First Report Managed Care

Advertisement

Advertisement

Advertisement